Generics Market Outlook: 2015

Date: October 1, 2010
Pages: 180
Price:
US$ 7,600.00
Publisher: Datamonitor
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: GBD4D2C853CEN
Leaflet:

Download PDF Leaflet

Generics Market Outlook: 2015
Introduction

Historical and forecast analysis of the entire generics industry from 2005 through to 2015. Strategic dynamics within the sector are broken down by company, geography, therapy area and formulation. See how Big Pharma companies' strategic shift away from blockbuster small molecule products will impact generics companies.

Features and benefits
  • Analyze historical and forecast generics sales by geography, therapy area, formulation and company
  • Analyze the relationship between the branded prescription pharmaceutical industry and the generics sector
Highlights

The generics industry has developed significantly over the past decade and represents an integral element of the broader prescription pharmaceutical market. This role as the ‘commoditizer’ of the pharmaceutical industry will remain intact; however, the level of sales growth achieved by the generics industry in recent years will not be sustainable.

Sales growth will slow due to a fundamental change in the growth strategies implemented by branded players - Big Pharma in particular - which have become characterized by a smaller number of blockbuster launches and increased investment in biologics and vaccines.

Your key questions answered
  • Assess the outlook for the generics industry through to 2015
  • Evaluate the effects of the end of Big Pharma’s blockbuster era on the generics industry
Executive Summary
Key findings
Introduction to the global generics market
  Big Pharma has learnt to take the generics industry seriously
  Industry growth has become dependent on blockbuster expiries
  Biosimilars the next phase of development for the generics industry?
  Historical growth analysis 2005-09
  US market central to industry growth
  Generic players have ‘piggybacked’ blockbuster boom
Market growth forecast to slow over 2009-15
  US market will act as primary growth resistor
  Branded players have adapted – generic industry will be forced to follow
  Fundamental shift in generic landscape over next decade
  Biosimilars – the key growth opportunity for generics manufacturers?
  US approval pathway delay highlights ‘bioequivalence’ issue
  Biosimilars market could attract diverse competition
  Erosion dynamics will be much different to typical generics market

ABOUT THIS SECTOR REPORT

PharmaVitae Explorer database
Chapter structure
  Methodology
  Market analysis
  Company analysis

METHODOLOGY

Definitions
Forecasting methodology
  Marketed products
  New generic launches
  Biosimilars

MARKET ANALYSIS

Key findings
Global generics market sales and growth rate analysis, 2005–15
  Generic sales growth analysis, 2005-09
  Generic sales growth analysis, 2009-15
  Marketed and pipeline growth analysis, 2005-15
Geographic analysis
  US market to deliver significant reduced sales growth
  Non-US generic markets performance
  Commoditization of generics market will fuel RoW/emerging market growth
Therapy area analysis
  Central nervous system
  Cardiovascular
  Infectious diseases
  Non-core generic market therapy areas
Formulation analysis

COMPANY ANALYSIS

Key findings
Leading generics companies
Teva
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Sandoz
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Mylan
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Apotex
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Hospira
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Ranbaxy
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis
Watson
  Sales analysis
  Therapy area analysis
  Formulation analysis
  Geographic analysis

APPENDIX

References
Abbreviations
Exchange rates

Ask Your Question

Generics Market Outlook: 2015
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: